Lenire
FDA approved Tinnitus Treatment Device
How does it work?
What Is The Research Behind Lenire?
Lenire is the first device of its kind to receive a grant of approval from the FDA to treat tinnitus. Results of effectiveness have been proven in three large clinical trials.
First trial: 80% of Lenire’s first clinical trial patients had a reduction in tinnitus severity that sustained for at least 12 months after treatment.
Second trial: 91% of Lenire’s second clinical trial patients had a reduction in tinnitus severity that sustained for at least 12 months after treatment.
Third trial: Majority of patients with moderate or worse tinnitus had significant relief using Lenire when sound-only had no meaningful impact.
Patient Stories
Lenire Helped Vickie Forgot About Tinnitus
“I think devices like Lenire show that there is hope out there.”
Lenire gave Irina her life back
“I would definitely recommend Lenire to other people. It was basically a lifesaver for me!”
Lenire Helped Dorothy Unwind to Sleep
“Lenire was very easy to use. When I saw it first I was a bit wary but then when I used it, it was very simple.”
Lenire Gave Hugh Control Over His Tinnitus
“After six weeks, I noticed improvement. After another six weeks, I noticed even more improvement. It has changed my mindset.”
